quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·1515d
PRRelease
Horizon Therapeutics Public Limited Company logo
Willis Towers Watson Public Limited Company logo

Horizon Therapeutics plc Launches #RAREis Representation Program to Elevate Global Rare Disease Equity

HZNP· Horizon Therapeutics Public Limited CompanyWLTW· Willis Towers Watson Public Limited Company
Health CareFinance
Original source

Companies

  • HZNP
    Horizon Therapeutics Public Limited Company
    Health Care
  • WLTW
    Willis Towers Watson Public Limited Company
    Finance

Recent analyst ratings

  • Nov 1HZNPUpdateH.C. Wainwright$74.00
  • Aug 4HZNPUpdateSVB Leerink-
  • Jun 14HZNPUpdateUBS$139.00
  • Jun 6HZNPUpdateSVB Leerink$95.00
  • May 23HZNPUpdateSVB Leerink$95.00
  • Mar 15HZNPUpdateOppenheimer$140.00

Related

  • PR428d
    Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting
  • SEC920d
    SEC Form 15-12G filed by Horizon Therapeutics Public Limited Company
  • INSIDER930d
    Watkins Thomas returned $20,550,600 worth of Ordinary Shares to the company (176,400 units at $116.50), closing all direct ownership in the company (SEC Form 4)
  • INSIDER930d
    Mahony Susan returned $2,172,842 worth of Ordinary Shares to the company (18,651 units at $116.50), closing all direct ownership in the company (SEC Form 4)
  • INSIDER930d
    Witz Pascale returned $5,353,292 worth of Ordinary Shares to the company (45,951 units at $116.50), closing all direct ownership in the company (SEC Form 4)
  • INSIDER930d
    Grey Michael G returned $11,346,168 worth of Ordinary Shares to the company (97,392 units at $116.50), closing all direct ownership in the company (SEC Form 4)
  • INSIDER930d
    Daniel William F returned $9,271,652 worth of Ordinary Shares to the company (79,585 units at $116.50), closing all direct ownership in the company (SEC Form 4)
  • INSIDER930d
    Himawan Jeff returned $10,371,762 worth of Ordinary Shares to the company (89,028 units at $116.50), closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022